The ATM and ATR kinases regulate centrosome clustering and tumor recurrence by targeting KIFC1 phosphorylation

Guangjian Fan1, Lianhui Sun1, Ling Meng2

  • 1Translational Medicine Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 201620, Shanghai, China.

Nature Communications
|January 5, 2021
PubMed

Insights

Centrosome amplification drives cancer recurrence and drug resistance. This study reveals KIFC1 phosphorylation by ATM/ATR kinases promotes survival of cancer cells with amplified centrosomes, suggesting KIFC1 inhibition as a therapeutic strategy.

Area of Science:

  • Cell Biology
  • Cancer Research
  • Molecular Oncology

Background:

  • Drug resistance and tumor recurrence are significant obstacles in cancer treatment.
  • Cancer cells frequently exhibit centrosome amplification, a condition where cells possess more than two centrosomes.
  • Centrosome clustering enables cancer cells with supernumerary centrosomes to undergo bipolar division, promoting survival and proliferation.

Purpose of the Study:

  • To elucidate the regulatory mechanisms of centrosome clustering in cancer cells.
  • To investigate the role of KIFC1 (kinesin family member C1) in centrosome clustering and its association with tumor recurrence.
  • To explore the potential of targeting KIFC1 phosphorylation as a therapeutic strategy against drug-resistant cancers.

Main Methods:

  • Investigated the association between KIFC1 expression and tumor recurrence.
  • Examined the phosphorylation of KIFC1 at Ser26 by ATM and ATR kinases under DNA damaging conditions.
  • Assessed the effect of KIFC1 phosphorylation inhibition on centrosome clustering, cancer cell survival, drug resistance, and tumor recurrence in preclinical models.

Main Results:

  • KIFC1 was found to be positively associated with tumor recurrence in cancer.
  • DNA damaging treatments induced ATM/ATR-mediated phosphorylation of KIFC1 at Ser26, which selectively promoted the survival of cancer cells with amplified centrosomes.
  • Inhibition of KIFC1 phosphorylation effectively repressed centrosome clustering, leading to decreased drug resistance and tumor recurrence.

Conclusions:

  • KIFC1 acts as a crucial regulator of centrosome clustering and is a prognostic marker for tumor recurrence.
  • Cancer cells can acquire therapeutic resistance and recurrence by activating centrosome clustering under DNA damage stress.
  • Targeting KIFC1 phosphorylation presents a promising new therapeutic avenue for overcoming drug resistance and preventing tumor recurrence in cancer patients.

Related Concept Videos

Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
3.2K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.2K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.1K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.7K
Centrosome Duplication02:25

Centrosome Duplication

The primary microtubule organizing center (MTOC) in animal cells is the centrosome. A centrosome has two cylindrical centrioles at its core. Each centriole consists of nine sets of three microtubules held together by proteins. The centrioles are positioned at right angles to each other and surrounded by a shapeless protein cloud called the pericentriolar matrix, or pericentriolar material (PCM).
To ensure that each daughter cell receives a centrosome after cell division, centrosome duplication...
4.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.1K